Glucocorticoid receptors are distributed in various cells of the body and participate in the regulation of metabolism and immunity in response to glucocorticoids. RNA mA methylation participates in various metabolic and inflammatory responses, yet it remains elusive whether mA is involved in GR regulation during immune activation. Here, we observed uncoupled GR responses with increased mRNA yet suppressed protein levels in the LPS-challenged broilers chicken liver, in association with global elevation of RNA mA methylation, especially in the expression of METTL3 and YTHDF2. Further analysis using isolated primary hepatocytes and Kupffer cells revealed that such uncoupled GR responses and mA hypermethylation occurred specifically in KCs. The same GR and mA responses were reproduced in LPS-activated KC cell line, implying a possible role of mA in the post-transcriptional suppression of GR in KC. Indeed, mA inhibitor cycloleucine alleviated LPS-induced GR protein suppression, whilst GR antagonist RU486 had no effect on global mA methylation in KC. We observed that YTHDF2 siRNA can alleviate LPS-induced GR mRNA stability decrease. Subsequently, specific mA sites on GR were predicted and verified. Mutation mA sites and luciferase reporter assay was also applied to validate these findings. Mechanistically, mA methylation on the transcripts of GR impairs its mRNA stability in a YTHDF2-dependent manner, which leads to the decrease of its protein. Our study indicates successive roles of RNA mA modification in the down regulation of GR expression, which provides new drug targets for epigenetic therapy of liver inflammation.